Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Disease Progression × tivozanib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Disease Progression 1 Carcinoma, Renal Cell 1

Interventions

Nivolumab 2 venetoclax 1 tivozanib 1 pembrolizumab 1 niraparib 1 ibrutinib 1 encorafenib 1 durvalumab 1 copanlisib 1 Oxaliplatin 1 Leucovorin 1 Interleukin-2 1 Gemtuzumab 1 Gemcitabine 1 Folfox protocol 1 Fluorouracil 1 Cisplatin 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04987203 2025-08-22

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

AVEO Pharmaceuticals, Inc.

Phase 3 Active not recruiting

Carcinoma, Renal Cell, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡